A set of chameleon-like immune cells could be contributing to severe asthma in some patients.Intermediate group 2 i ...

A study reveals that shape-shifting immune cells, intermediate ILC2s, may contribute to severe asthma and resistance to ...

Researchers at McMaster University have made an important discovery in the field of asthma research, identifying a new ...

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

Current treatments focus on eosinophilic asthma, neglecting non-eosinophilic types. Developments in biologic therapies for severe asthma, challenges remain in managing T-helper cell type 2 (T2)-low ...

The following is a summary of “Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a ...

Juan Celedón and his research team have altered the possibilities of future asthma treatment by uncovering a new way to ...